Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Changes in hemostatic parameters after oral and transdermal hormone therapy in postmenopausal women.

Polac I, Borowiecka M, Wilamowska A, Bijak M, Ponczek MB, Nowak P.

Gynecol Endocrinol. 2011 Sep;27(9):692-5. doi: 10.3109/09513590.2010.526662. Epub 2010 Oct 28.

PMID:
20979540
2.

Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration.

Połać I, Borowiecka M, Wilamowska A, Nowak P.

Gynecol Endocrinol. 2013 Feb;29(2):165-8. doi: 10.3109/09513590.2012.730567. Epub 2012 Nov 2.

PMID:
23116237
3.

Changes in hemostatic parameters after oral hormone therapy in postmenopausal women.

Borowiecka M, Polac I, Nowak P, Radwan P, Ponczek MB, Wachowicz B.

J Womens Health (Larchmt). 2010 Dec;19(12):2267-70. doi: 10.1089/jwh.2010.2040. Epub 2010 Nov 7.

PMID:
21054215
4.
5.

Effects of oral and transdermal estrogen/progesterone regimens on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial.

Scarabin PY, Alhenc-Gelas M, Plu-Bureau G, Taisne P, Agher R, Aiach M.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):3071-8.

6.
8.

Effect of hormone therapy on the enteroinsular axis.

Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.

Menopause. 2005 Sep-Oct;12(5):630-638.

PMID:
16145319
9.

Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis.

Teede HJ, McGrath BP, Smolich JJ, Malan E, Kotsopoulos D, Liang YL, Peverill RE.

Arterioscler Thromb Vasc Biol. 2000 May;20(5):1404-9.

10.

The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.

Roach RE, Lijfering WM, Helmerhorst FM, Cannegieter SC, Rosendaal FR, van Hylckama Vlieg A.

J Thromb Haemost. 2013 Jan;11(1):124-31. doi: 10.1111/jth.12060.

11.

Transdermal estrogen replacement therapy: beneficial effects on hemostatic risk factors for cardiovascular disease.

Lindoff C, Peterson F, Lecander I, Martinsson G, Astedt B.

Maturitas. 1996 May;24(1-2):43-50.

PMID:
8794433
12.

Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: a randomized placebo-controlled study.

Post MS, van der Mooren MJ, van Baal WM, Blankenstein MA, Merkus HM, Kroeks MV, Franke HR, Kenemans P, Stehouwer CD.

Am J Obstet Gynecol. 2003 Nov;189(5):1221-7.

PMID:
14634544
13.
14.

Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women.

Vehkavaara S, Silveira A, Hakala-Ala-Pietilä T, Virkamäki A, Hovatta O, Hamsten A, Taskinen MR, Yki-Järvinen H.

Thromb Haemost. 2001 Apr;85(4):619-25.

PMID:
11341495
15.

Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.

Yilmazer M, Fenkci V, Fenkci S, Sonmezer M, Aktepe O, Altindis M, Kurtay G.

Maturitas. 2003 Dec 10;46(4):245-53.

PMID:
14625121
16.

Oxidative stress measured by carbonyl groups level in postmenopausal women after oral and transdermal hormone therapy.

Polac I, Borowiecka M, Wilamowska A, Nowak P.

J Obstet Gynaecol Res. 2012 Sep;38(9):1177-81. doi: 10.1111/j.1447-0756.2011.01842.x. Epub 2012 Apr 30.

PMID:
22540414
18.

B-type natriuretic peptide after hormone therapy in postmenopausal women with chest pain and normal coronary angiogram.

Kawano H, Nagayoshi Y, Soejima H, Tanaka Y, Hokamaki J, Miyamoto S, Miyazaki Y, Yamabe H, Ogawa H.

Menopause. 2008 Mar-Apr;15(2):352-6.

PMID:
18090872
19.

Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.

Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H.

Menopause. 2007 Nov-Dec;14(6):978-84.

PMID:
17595593
20.

Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.

Yasui T, Uemura H, Tomita J, Umino Y, Yamada M, Kuwahara A, Matsuzaki T, Maegawa M, Miura M, Irahara M.

Menopause. 2006 Jul-Aug;13(4):651-9.

PMID:
16837887

Supplemental Content

Support Center